KELSEY BROKAMP: Open Payments
NPI 1790039196 · VAN WERT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 97 payments from 20 companies in 2025. Trend: 2023 $2,347 · 2024 $1,932 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $223 |
| PFIZER INC. | 10 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $154 |
| Madrigal Pharmaceuticals | 9 | $136 |
| Janssen Biotech, Inc. | 6 | $116 |
| QOL Medical, LLC | 3 | $73 |
| Ardelyx, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
Products named: ENTYVIO, XIFAXAN, XELJANZ, REZDIFFRA, RINVOQ, SKYRIZI, TREMFYA, Sucraid.
Industry payments across OH — which companies pay providers there.
